|
Avanir Pharmaceuticals Announces New Findings from Dementia/Alzheimer's …
PR Newswire (press release) ALISO VIEJO, Calif., July 23, 2015 /PRNewswire/ — Avanir Pharmaceuticals, Inc. today announced new findings from the dementia/Alzheimer's disease cohort of the PRISM II study, a phase IV study evaluating the safety and effectiveness of NUEDEXTA® in … |